scieee Science in your language
[en] (orig)

Anxiety and fear of COVID-19 in the UK general population: a cross-sectional study

Abstract

There is still a generalized feeling of uncertainty in the population due to the coronavirus disease 2019 (COVID-19) pandemic, as restrictions on daily routines and social contact, accompanied by a large number of infections, negatively affect different areas of people’s lives and, therefore, their mental health. The aim of the present study was to assess the presence of anxiety and fear of COVID-19 in the general UK population, using the Anxiety and Fear to COVID-19 Assessment Scale (Ansiedad y Miedo al COVID-19) (AMICO) scale. A descriptive, cross-sectional study based on a questionnaire was conducted in a sample of the UK general population in 2021. Socio-demographic and employment variables were included. The AMICO scale was included to measure fear and anxiety about COVID-19. The relationship between variables was studied with a categorical regression analysis. In general, participants regarded themselves as well-informed about the pandemic, although 62.6% had only received 1 dose of the vaccine. Regarding the AMICO scale the total score was 4.85 (out of 10; standard deviation 2.398). Women showed higher scores for the AMICO than men. The bivariate analysis revealed statistically significant differences in relation to self-confidence, amount of information received, and vaccination variables as related to the mean AMICO scores. An average level of anxiety and fear of COVID-19 is shown in the general UK population, which is lower than most of the studies that assessed the impact of the pandemic on the general population.

Read accessible full text

Anxiety and fear of COVID-19 in the UK general population: a cross-sectional study

Author: Morgado-Toscano, Cristina; Gómez Salgado, Juan; Fagundo Rivera, Javier; Navarro-Abal, Yolanda; Rodríguez-Jiménez, Lucas; Climent-Rodríguez, José Antonio; Allande Cussó, Regina
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Year: 2023
DOI: 10.1097/MD.0000000000033045
Source: https://idus.us.es/bitstreams/77992c3a-fed1-4e3c-8151-a548e410c9cf/download
Obse a ional S udy
1
Medicine®
Anxie y and ea o COVID-19 in he UK gene al
popula ion
A c oss-sec ional s udy
C is inaMo gado-Toscano, RNa,b, JuanGómez-Salgado, PhDc,d,* , Ja ie Fagundo-Ri e a, PhDe,
YolandaNa a o-Abal, PhD , LucasRod íguez-Jiménez, RNg, José An onioClimen -Rod íguez, PhD ,
ReginaAllande-Cussó, PhDh
Abs ac
The e is s ill a gene alized eeling o unce ain y in he popula ion due o he co ona i us disease 2019 (COVID-19) pandemic, as
es ic ions on daily ou ines and social con ac , accompanied by a la ge numbe o in ec ions, nega i ely a ec di e en a eas
o people’s li es and, he e o e, hei men al heal h. The aim o he p esen s udy was o assess he p esence o anxie y and ea
o COVID-19 in he gene al UK popula ion, using he Anxie y and Fea o COVID-19 Assessmen Scale (Ansiedad y Miedo al
COVID-19) (AMICO) scale. A desc ip i e, c oss-sec ional s udy based on a ques ionnai e was conduc ed in a sample o he UK
gene al popula ion in 2021. Socio-demog aphic and employmen a iables we e included. The AMICO scale was included o
measu e ea and anxie y abou COVID-19. The ela ionship be ween a iables was s udied wi h a ca ego ical eg ession analysis.
In gene al, pa icipan s ega ded hemsel es as well-in o med abou he pandemic, al hough 62.6% had only ecei ed 1 dose o
he accine. Rega ding he AMICO scale he o al sco e was 4.85 (ou o 10; s anda d de ia ion 2.398). Women showed highe
sco es o he AMICO han men. The bi a ia e analysis e ealed s a is ically signi ican di e ences in ela ion o sel -con idence,
amoun o in o ma ion ecei ed, and accina ion a iables as ela ed o he mean AMICO sco es. An a e age le el o anxie y and
ea o COVID-19 is shown in he gene al UK popula ion, which is lowe han mos o he s udies ha assessed he impac o he
pandemic on he gene al popula ion.
Abb e ia ions: AMICO = Anxie y and Fea o Co id-19 Assessmen Scale (Ansiedad y Miedo al COVID-19), COVID-19 =
co ona i us disease 2019, EFA = explo a o y ac o analysis, FCV-19 = ea o COVID-19.
Keywo ds: anxie y, COVID-19, ea , psychological dis ess, UK
1. In oduc ion
In Decembe 2019, he i s case o pneumonia caused by he
new o m o co ona i us was de ec ed in Wuhan, China, wi h
se e e acu e espi a o y synd ome co ona i us 2 con i med as
he causa i e agen on Janua y 7, 2020.[1] The eme gence o his
new i us igge ed a con using si ua ion, as i quickly sp ead
o o he p o inces and egions o he coun y and subsequen ly
wo ldwide and was cha ac e ized by an ex emely high in ec-
ion a e and ela i ely high mo ali y.[2]
Thus, on Janua y 30, 2020, he Wo ld Heal h O ganiza ion
decla ed his disease a “public heal h eme gency o
in e na ional conce n.”[3] The UK was one o he i s coun-
ies a ec ed in Eu ope, wi h i s i s 2 con i med cases o
co ona i us disease 2019 (COVID-19) de ec ed on Janua y
31, 2020.[4] F om his poin onwa ds, cases began o inc ease
exponen ially, leading o he decla a ion o a lockdown o
he en i e UK popula ion om Ma ch 23, 2020, un il July 31,
2020.[5] Howe e , he UK’s ini ial esponse o he pandemic
was slow.[6] Due o he la ge olume o in ec ed people, he e
was e en a need o c ea e hospi als wi h he speci ic pu pose
o ea ing hese pa ien s, as was he case o he “Nigh ingale
Hospi al,” which was buil in London o ecei e up o 4000
The au ho s ha e no unding o disclose.
The au ho s ha e no con lic s o in e es o disclose.
The da ase s gene a ed du ing and/o analyzed du ing he cu en s udy a e
a ailable om he co esponding au ho on easonable eques .
Pe mission o conduc his s udy was ob ained om he Na ional Heal h Se ice
(NHS) Heal h Resea ch Au ho i y, IRAS p ojec ID 283849, REC e e ence 20/
HRA/3997. This s udy also complied wi h he guidelines se in he Decla a ion
o Helsinki ega ding e hical p inciples o medical esea ch in ol ing human
subjec s.
a Heal h Sciences Doc o a e School, Uni e si y o Huel a, Huel a, Spain, b
Heal h Sciences Resea ch Uni : Nu sing, Uni e si y o Coimb a, Coimb a,
Po ugal, c Depa men o Sociology, Social Wo k and Public Heal h, Facul y
o Labou Sciences, Uni e si y o Huel a, Huel a, Spain, d Sa e y and Heal h
Pos g adua e P og amme, Uni e sidad Espí i u San o, Guayaquil, Ecuado , e
Cen o Uni e si a io de En e me ía C uz Roja, Uni e si y o Se ille, Se ille, Spain,
Facul y o Educa ion Science, Uni e si y o Huel a, Huel a, Spain, g Eme gency
Depa men , Royal F ee London NHS Founda ion T us , h Depa men o Nu sing,
Uni e si y o Se ille, Se ille, Spain.
* Co espondence: Juan Gómez-Salgado, Depa men o Sociology, Social Wo k
and Public Heal h, Facul y o Labou Sciences, Uni e si y o Huel a, A enida T es
de ma zo, s/n, Huel a 21007, Spain (e-mail: [email p o ec ed]).
Copy igh © 2023 he Au ho (s). Published by Wol e s Kluwe Heal h, Inc.
This is an open-access a icle dis ibu ed unde he e ms o he C ea i e
Commons A ibu ion-Non Comme cial License 4.0 (CCBY-NC), whe e i is
pe missible o download, sha e, emix, ans o m, and buildup he wo k p o ided
i is p ope ly ci ed. The wo k canno be used comme cially wi hou pe mission
om he jou nal.
How o ci e his a icle: Mo gado-Toscano C, Gómez-Salgado J, Fagundo-Ri e a
J, Na a o-Abal Y, Rod íguez-Jiménez L, Climen -Rod íguez JA, Allande-Cussó
R. Anxie y and ea o COVID-19 in he UK gene al popula ion: A c oss-sec ional
s udy. Medicine 2023;102:10(e33045).
Recei ed: 18 Oc obe 2022 / Recei ed in inal o m: 30 Janua y 2023 / Accep ed:
31 Janua y 2023
h p://dx.doi.o g/10.1097/MD.0000000000033045
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
2
Mo gado-Toscano e al. • Medicine (2023) 102:10 Medicine
pa ien s wi h COVID-19.[6] Since hen, up o 6 wa es o in ec-
ions ha e occu ed in Eu ope, o cing coun ies such as he
UK o ake d as ic measu es o cu b he numbe o in ec ed
people. Cu en ly, 11,518,255 cases and 147,723 dea hs ha e
been con i med.[7]
To add ess his si ua ion, on Decembe 8, 2020, he UK
became he i s coun y o ini ia e a COVID-19 accina ion
p og am. Ini ially, accina ion was p io i ized o he elde ly
o e 80 yea s o age and on line heal hca e wo ke s,[8] each-
ing 47,051,876 people who a e cu en ly ully accina ed, ha
is, 70.40% o he UK popula ion.[7]
Howe e , al hough accina ion has conside ably educed he
likelihood o de eloping se e e disease om he i us, i has no
p o ed o be an e ec i e measu e o educe he numbe o in ec-
ions due o he mul iple mu a ions he i us has unde gone. All
his leads o a gene alized eeling o unce ain y in he popula-
ion, inc eased by he es ic ions on mobili y and social con ac
imposed in all coun ies, hus nega i ely a ec ing di e en a eas
o people’s li es and men al heal h.[9]
In gene al, he e ec s caused by COVID-19 on he physical
and men al heal h o he popula ion ha e been and con inue o
be s udied. Apa om he medical consequences o COVID-19,
his pandemic has also been cha ac e ized by i s p opaga ion
o e ime, hus de ining he e m “co onaphobia” o designa e
he long- e m men al illnesses ela ed o he pandemic.[10]
This aises he need o enewal and o he de elopmen o
ools ha measu e speci ically pandemic- ela ed ea and anx-
ie y in he gene al popula ion. One o he i s scales designed
o his pu pose was he ea o COVID-19 (FCV-19).[11] The
Anxie y and Fea o Co id-19 Assessmen Scale (Ansiedad y
Miedo al COVID-19) (AMICO) was designed ollowing he
me hodology p oposed by Eps ein e al.[12] Ini ially, i was
based on he 10 i ems o he FCV-19 scale, which we e e alu-
a ed by a panel o expe s p io o he psychome ic analyses
conduc ed o ha s udy.[11] Wi h hese 10 i ems, a ansla-
ion/back- ansla ion p ocess was applied and he c oss-cul-
u al adap a ion was s udied by a panel o expe s. I was
made up o 10 subjec s, namely p o esso s and esea che s
om di e en Spanish uni e si ies, wi h he academic le el
o Doc o o O icial Mas e and whose a eas o knowledge
we e public heal h, amily medicine, clinical psychology, nu s-
ing, and social wo k. In addi ion o he 10 i ems, he panel
o expe s p oposed and ag eed, using he Delphi echnique,
o conside 8 new i ems measu ing he anxie y cons uc . The
18 i ems we e hen submi ed o a new Delphi ound. The
explo a o y ac o analysis (EFA) p oduced a dimensional
ma ix o 16 i ems and 2 ac o s, explaining 64.8% o he
a iance (Kaise -Meye -Olkin es = 0.94; Ba le es : P =
.001). The eliabili y s udy p o ided a C onbach α alue o
0.92. The esponse op ions o he AMICO scale ange om 1
o 10 poin s, whe e 1 co esponds o “s ongly disag ee” and
10 o “s ongly ag ee.”[10] Likewise, he AMICO scale was
alida ed concu en ly wi h he S a e-T ai Anxie y In en o y
ques ionnai e.[13]
As in Spain, nu ses in he UK ha e el o e whelmed by he
hea y wo kload. Likewise, he gene al popula ion has also been
se e ely a ec ed in his espec . The AMICO scale has p o ed
o be a alid and eliable ool in he Spanish gene al popula-
ion o iden i y he ex en o which he COVID-19 pandemic
has a ec ed he men al heal h o he popula ion and hus o e
speci ic in e en ions o add ess a global popula ion p oblem.
The e o e, he e is a need o alida e his scale in he UK popu-
la ion as well.
Wi h ega d o he so-called ad e se e ec s, o e he las
40 yea s, wi h he i s In e go e nmen al Panel on Clima e
Change in 1988, a consensus has eme ged on he ole o
human ac i i y in inc easing global empe a u e and accele -
a ing clima e change, ac o s ha signi ican ly h ea en public
heal h.[14] These h ea s ha e a di ec impac on heal h and
a e expec ed o cause 250,000 dea hs pe yea wo ldwide
be ween 2030 and 2050, mainly om malnu i ion, in ec-
ious diseases, and hea s ess, acco ding o he Wo ld Heal h
O ganiza ion.[15]
Fu u e esea ch on ad e se e ec s also helps o p edic in ec-
ious espi a o y diseases, including COVID-19, and o he
non- espi a o y diseases.[16] Gi en hese possible ad e se e ec s
and in an a emp o an icipa e he p oblem in o de o p e en
possible ela ed men al heal h condi ions, i would be ad is-
able o de elop new s udies ha assess he p esence o anxi-
e y and ea in speci ic popula ion g oups such as he elde ly,
child en, people wi h men al heal h p oblems, and ail people
wi h he aim o explo ing wha hey expe ience when aced
wi h ce ain heal h si ua ions. Knowing how ce ain popula-
ion g oups beha e in he ace o an ad e se e ec o his ype,
such as he COVID-19 pandemic, can be o g ea help o u u e
in e en ions.[17]
In his con ex , he aim o he p esen s udy was o assess he
p esence o anxie y and FCV-19 in he gene al UK popula ion,
using he AMICO scale.
2. Ma e ials and me hods
2.1. Design
A desc ip i e, c oss-sec ional s udy based on a ques ionnai e
was conduc ed acco ding o he He zog e al classi ica ion,[18]
which was dissemina ed be ween Ap il and June 2021.
2.2. Popula ion and sample
This s udy was conduc ed in he UK, a coun y wi h a popula-
ion o 67,025,542 as o 2019.[19] A sample o a leas 239 peo-
ple was es ima ed o his s udy, wi h a con idence le el o 95%,
a p ecision o 3%, and an expec ed loss a io o 15%. Finally,
he o al sample o his s udy was 657.
2.3. Pa icipan s and public in ol emen
This s udy de eloped i s esea ch ques ion wi h a basis on expe-
iences and psychological needs exp essed by he public. The
public was no in ol ed in he design o he s udy. Pa icipan s
we e encou aged o dissemina e he ques ionnai e o ela i es
who li ed in he UK. The pa icipan s could ag ee on ecei ing
he in es iga ion esul s, once he s udy had concluded and ou -
comes we e published.
2.4. Va iables
Socio-demog aphic a iables such as sex, age, egion o esi-
dence, ma i al s a us, le el o educa ion, numbe o cohabi an s,
size o he dwelling, heal h s a us, diagnosis and hospi al admis-
sions o COVID-19, olun a y sel -con inemen o a oid in ec-
ion, accina ion, and side e ec s we e included. Employmen
a iables we e also included, such as employmen s a us, wo k
sec o , and sala y. Finally, he AMICO scale a iable was
included o measu e ea and anxie y abou COVID-19.
2.5. Ins umen s
The Anxie y and Fea o COVID-19 Assessmen (AMICO) scale
was used. This scale was al eady designed and alida ed in p e-
ious s udies. The alida ion o he AMICO_UK scale was ca -
ied ou in a p e ious s udy. Fo he adap a ion o he AMICO
scale o he UK con ex , a p ocess o di ec ansla ion in o
English and back- ansla ion in o Spanish was ca ied ou in
o de o e i y ha he ansla ed e sion e lec ed he same con-
en as he o iginal e sions.[20] This double ansla ion p ocess
was pe o med by 2 ansla o s who we e na i e Spanish speak-
e s, bu who esided and wo ked in he UK and had a minimum
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
3
Mo gado-Toscano e al. • Medicine (2023) 102:10 www.md-jou nal.com
o a Mas e ’s deg ee. The ansla ed e sion was e alua ed by a
panel o 10 expe s.[21]
Subsequen ly, a pilo es was ca ied ou wi h 20 subjec s o
de ec unde s anding p oblems, a e which he ield s udy was
ini ia ed wi h a sample o subjec s li ing in he UK.
P io o he EFA, a Kaise -Meye -Olkin measu e o 0.961
and a signi icance le el o 0.000 in he Ba le es o sphe ici y
we e ob ained. Wi h hese esul s, he EFA was implemen ed in
acco dance wi h he c i e ia o p incipal componen s analysis
and a imax o a ion, which yielded a ac o ial solu ion o 2
dimensions and 16 i ems. This ac o ial solu ion explained 76%
o he a iance.
A eliabili y s udy was also ca ied ou , p o iding an o e all
C onbach α alue o 0.964, and 0.90 and 0.92 o each o he
ac o s.
A e ha , con i ma o y ac o analysis was pe o med o
assess cons uc alidi y, which o e ed he ollowing alues: dis-
c epancy di ided by deg ee o eedom = 4.59 (P = .17; No med
Fi Index = 0.97; Tucke -Lewis index = 0.956; compa a i e i
index = 0.976; oo mean squa e e o o app oxima ion = 0.07;
and Quad a ic s anda dized esidual = 0.04).
2.6. P ocedu e/se ings
A non-p obabilis ic snowball sampling was ca ied ou . Fo he
ec ui men o he sample subjec s, an online ques ionnai e was
elabo a ed using Qual ics©, which included in o ma ion abou
he s udy and he i ems ela ed o he a iables o said s udy.
The ques ionnai e was sen o he popula ion h ough social
ne wo ks.
All pa icipan s we e duly in o med o he pu pose o he
s udy, as well as o he possibili y o pa icipa ing olun a ily,
anonymously, and con iden ially. To pa icipa e, subjec s had o
ick a box o g an pa icipa ion on a olun a y and anonymous
basis. Once his box was icked, pa icipan s had access o he
ques ionnai es. O he wise, hey could no be accessed.
2.7. Da a analysis
The Kolmogo o –Smi no es was i s applied o es no mal-
i y, ob aining a P < .005 and allowing he use o non-pa ame ic
es s. Con as es s we e pe o med wi h he Mann–Whi ney U
and K uskal–Wallis es . The co ela ion be ween quan i a i e
a iables was checked wi h he Kendall au b es .
The ela ionship be ween quali a i e a iables was checked
wi h a ca ego ical eg ession analysis, which included a iance,
coe icien o de e mina ion (R2), eg ession analysis, and signi -
icance o model pa ame e s.[22]
Uni a ia e and bi a ia e desc ip i e analyses we e pe o med
using he SPSS© s a is ical so wa e[23] (IBM, A monk, NY). Fo
he calcula ion, he op imal scaling op ion was chosen in he
so wa e.
2.8. E hical aspec s
This s udy in he UK is pa o he IMPACTCOVID-19 in e -
na ional in es iga ion p ojec , which ollowed he me hodology
o a p e ious in es iga ion in Spain consis ing o he alida ion
and c oss-cul u al adap a ion o he AMICO scale[12] and con-
sequen ly assessmen in a speci ic popula ion.[24] As men ioned
be o e, he AMICO scale was designed by a eam o di e en
p o essionals,[17] based on he FCV-19 scale.[11] No pe missions
no licenses we e equi ed o i s use.
Pe mission o conduc his s udy was ob ained om he
Na ional Heal h Se ice Heal h Resea ch Au ho i y, IRAS p oj-
ec ID 283849, REC e e ence 20/HRA/3997. This s udy also
complied wi h he guidelines se in he Decla a ion o Helsinki
ega ding e hical p inciples o medical esea ch in ol ing
human subjec s.[25]
All indi iduals in he sample ag eed o pa icipa e on a
olun a y basis by eading and signing in o med consen .
Con iden iali y o da a and anonymi y o pa icipan s was
ensu ed, always espec ing he p o ec ion o he igh s o he
pa icipan s o he s udy.
3. Resul s
3.1. Desc ip i e analysis
The sample selec ed o he s udy consis ed o 657 people li ing
in he UK. As can be seen in Table1, o he o al sample, 80.5%
we e women, wi h a mean age o 48.25 yea s (Table1).
As ega ds income, 71.7% said hey had su icien esou ces
o make ends mee .
Wi h ega d o gene al heal h s a us, he mean sco e o his
a iable was 6.67. Also, 58.8% had ne e sel -con ined o p o-
ec hemsel es, al hough he majo i y did conside hemsel es
o be a isk o one eason o ano he .
In gene al, pa icipan s ega ded hemsel es as well-in o med
abou he pandemic, wi h a mean sco e o his a iable o 7.94
poin s. Also, a he ime o he su ey, only 14.5% o he sam-
ple had been accina ed wi h bo h doses and 62.6% had only
ecei ed 1 dose; on he o he hand, 6.2% claimed hey did no
wan o ge he accine. O hose who had been accina ed,
35.6% had had no side e ec s a e he adminis a ion bu jus
pain a he injec ion spo (Table1).
Rega ding he AMICO scale a iable, he mean AMICO o al
sco e was 4.85 (SD = 2.398), wi h a ange o sco es om 1 o
10.
On he o he hand, he Kolmogo o –Smi no es , wi h a
signi icance o 0.000, e ealed ha he dis ibu ion o sco es
ob ained on he AMICO scale did no ollow a no mal dis ibu-
ion, so non-pa ame ic es s we e pe o med.
The bi a ia e analysis e ealed s a is ically signi ican di -
e ences in ela ion o sex, end-o -mon h income, heal h s a us
sco e, sel -con idence, amoun o in o ma ion ecei ed, and ac-
cina ion a iables ela ed o he mean AMICO sco es (Table2).
Thus, women showed highe sco es on he AMICO scale han
men. In e ms o income, hose who did no make ends mee
showed highe le els o ea and anxie y abou COVID-19. In
addi ion, hose who had no sel -con ined o p o ec hemsel es
agains he disease go he highes sco es on his scale. On he
o he hand, hose who had no ye been accina ed wi h any
dose we e he mos ea ul and anxious (Table2).
3.2. Reg ession analysis
The calcula ion o he ca ego ical eg ession was implemen ed,
i s , wi h he mean o al sco e o he AMICO ques ionnai e
as he dependen a iable and he es o he a iables ha
showed signi ican di e ences in he desc ip i e bi a ia e anal-
ysis (Table3). In his sense, he esul s sugges ha women who
epo ed no ecei ing enough money o make ends mee , who
did no sel -con ine, and who had been accina ed wi h only 1
dose p esen ed highe le els o anxie y and FCV-19.
4. Discussion
The alida ion o he AMICO_UK scale was ca ied ou in a
p e ious s udy. Fo he adap a ion o he AMICO scale o he
UK con ex , a p ocess o di ec ansla ion in o English and
back- ansla ion in o Spanish was ca ied ou . The ansla ed
e sion was e alua ed by a panel o 10 expe s. Subsequen ly, a
pilo es was ca ied ou wi h 20 subjec s o de ec unde s and-
ing p oblems.[21]
On he o he hand, he s udy o pe cen iles and qua iles wi h
espec o he dis ibu ion o mean scale sco es allowed iden-
i ying 3 p oposed le els o anxie y using a box-and-whiske
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
4
Mo gado-Toscano e al. • Medicine (2023) 102:10 Medicine
plo . Le els we e iden i ied as low, wi h sco es anging om 0 o
4.7 poin s, in e media e, wi h sco es anging om 4.71 o 6.7
poin s, and high, wi h sco es anging om 6.71 o 10 poin s.
The analysis o he s a is ical signi icance o he di e ences
be ween he iden i ied le els, using he Mann–Whi ney U s a is-
ic o each pai o le els es ed, always ga e a alue o P = .000;
hus, i can be concluded ha he e a e signi ican di e ences
be ween he iden i ied le els, and he ele ance o hese di e -
ences is con i med by he Mann–Whi ney U s a is ic o each
pai o le els es ed.[17]
The esul s o he s udy showed an a e age le el o anxie y
and FCV-19 in he gene al UK popula ion, as measu ed by he
AMICO_UK scale. Howe e , mos o he e iewed s udies p o-
ide e idence o he high impac o he COVID-19 pandemic
Table 1
Desc ip ion o he sample p o ile.
Quan i a i e a iables Value Resul Range
Age Mean
S anda d de ia ion
48.25
14.861
Minimum = 16
Maximum = 80
No o co-dwelle s Mean
S anda d de ia ion
2.58
1.3
Minimum = 1
Maximum = 10
Heal h s a e sco e Mean
S anda d de ia ion
6.67
2.061
Minimum = 0
Maximum = 10
Le el o in o ma ion Mean
S anda d de ia ion
7.94
2.078
Minimum = 1
Maximum = 10
Quali a i e a iables Value Resul To al
Sex Male
Female
n = 120 (18.3%)
n = 529 (80.5%)
To al sample
657
Ma i al s a us Ma ied
Single
Widow/e
Sepa a ed/di-
o ced
Doesn’ say
O he
n = 318 (48.4%)
n = 174 (26.5%)
n = 25 (3.8%)
n = 63 (9.6%)
n = 17 (2.6%)
n = 60 (9.1%)
Educa ional le el Seconda y
Highe seconda y
Uni e si y
(Mas e ’s o
Doc o a e)
Uni e si y (deg ee)
Wi hou s udies
Doesn’ say
O he
n = 120 (18.3%)
n = 108 (16.4%)
n = 97 (14.8%)
n = 263 (40%)
n = 8 (1.2%)
n = 21 (3.2%)
n = 40 (6.1%)
Wo k si ua ion S udying
Doesn’ say
Full- ime ou side
o home
Full- ime om
home
Pa - ime ou side
o home
Pa - ime om
home
On sick lea e
Re i ed
Unemployed
O he
n = 14 (2.1%)
n = 13 (2%)
n = 134 (20.4%)
n = 116 (17.7%)
n = 81 (12.3%)
n = 50 (7.6%)
n = 21 (3.2%)
n = 135 (20.5%)
n = 39 (5.9%)
n = 54 (8.2%)
Su icien income Yes
No
No always
Doesn’ say
O he
n = 471 (71.7%)
n = 58 (8.8%)
n = 103 (15.7%)
n = 20 (3%)
n = 5 (0.8%)
COVID-19 diagnosis Yes
No
n = 69 (10.5%)
n = 586 (89.2%)
Sel -con inemen Yes
No
n = 264 (40.2%)
n = 386 (58.8%)
Vaccina ion Yes, wi h 2 doses
Yes, wi h 1 dose
No
No, I e use
accina ing
Doesn’ say
n = 95 (14.5%)
n = 411 (62.6%)
n = 105 (16%)
n = 41 (6.2%)
n = 5 (0.8%)
COVID-19 = co ona i us disease 2019.
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
5
Mo gado-Toscano e al. • Medicine (2023) 102:10 www.md-jou nal.com
Table 2
Bi a ia e desc ip i e analysis.
Va iables To al sample (n = 657) Mean AMICO sco e Con as hypo hesis
Sex
Male
Female
n = 120 (18.3%)
n = 529 (80.5%)
4.15
5.09
P = .000*
Ma i al s a us
Ma ied
Single
Widow/e
Sepa a ed/
di o ced
Doesn’ say
O he
n = 318 (48.4%)
n = 174 (26.5%)
n = 25 (3.8%)
n = 63 (9.6%)
n = 17 (2.6%)
n = 60 (9.1%)
4.82
4.89
4.83
4.81
4.6
5.55
P = .426‡
Educa ional le el
Seconda y
Highe
seconda y
Uni e si y
(Mas e ’s o
Doc o a e)
Uni e si y
(deg ee)
Wi hou s udies
Doesn’ say
O he
n = 120 (18.3%)
n = 108 (16.4%)
n = 97 (14.8%)
n = 263 (40%)
n = 8 (1.2%)
n = 21 (3.2%)
n = 40 (6.1%)
4.84
4.85
4.46
5.02
6.44
4.77
5.20
P = .239‡
Wo k si ua ion
S udying
Doesn’ say
Full- ime ou side
o home
Full- ime om
home
Pa - ime ou side
o home
Pa - ime om
home
On sick lea e
Re i ed
Unemployed
O he
n = 14 (2.1%)
n = 13 (2%)
n = 134 (20.4%)
n = 116 (17.7%)
n = 81 (12.3%)
n = 50 (7.6%)
n = 21 (3.2%)
n = 135 (20.5%)
n = 39 (5.9%)
n = 54 (8.2%)
5
4.81
4.55
5.4
4.55
5.25
5.93
4.75
5.09
5.47
P = .165‡
Su icien income
Yes
No
No always
Doesn’ say
O he
n = 471 (71.7%)
n = 58 (8.8%)
n = 103 (15.7%)
n = 20 (3%)
n = 5 (0.8%)
4.61
5.94
5.64
4.93
5.03
P = .000‡
COVID-19 diagnosis
Yes
No
n = 69 (10.5%)
n = 586 (89.2%)
4.44
4.96
P = .127*
Sel -con inemen
Yes
No
n = 264 (40.2%)
n = 386 (58.8%)
4.31
5.76
P = .000*
Vaccina ion
Yes, wi h 2 doses
Yes, wi h 1 dose
No
No, I e use
accina ing
Doesn’ say
n = 95 (14.5%)
n = 411 (62.6%)
n = 105 (16%)
n = 41 (6.2%)
n = 5 (0.8%)
4.60
5.16
5.11
2.53
4.00
P = .000‡
Age
Signi icance (SD) 48.25 (14.861) Tau b = −0.047†
No o co-dwelle s
Signi icance (SD) 2.58 (1.3) Tau b = 0.008†
Heal h s a e sco e
Signi icance (SD) 6.67 (2.061) Tau b = −0.2757†
Le el o in o ma ion
Signi icance (SD) 7.94 (2.078) Tau b = −0.120†
AMICO = Anxie y and Fea o COVID-19 Assessmen Scale (Ansiedad y Miedo al COVID-19), COVID-19 = co ona i us disease 2019, SD = s anda d de ia ion.
* Mann–Whi ney U. † Kendall au b. ‡ Analysis o a iance (ANOVA).
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023

6
Mo gado-Toscano e al. • Medicine (2023) 102:10 Medicine
on he men al heal h o he gene al popula ion. This is he case
o a s udy in Romania whe e, al hough olde people a e mo e
likely o ha e se ious p oblems associa ed wi h COVID-19 han
younge people, he esul s showed ha people cope wi h his
ea ega dless o age.[26] Ano he s udy conduc ed in Ge many
posi i ely ela ed FCV-19 o he pe cei ed isk o con ac ing
he disease.[27]
In line wi h he esul s o a e iew ha was de eloped
du ing he i s pandemic,[28] his s udy highligh ed ha hose
who habi ually wo e masks epo ed highe le els o FCV-19
han hose who did no comply wi h mask egula ions. This
ac could e eal ha COVID-19 is commonly associa ed wi h
se e e ad e se eelings, including ea , ange , o dep ession, bu
he in luence o indi iduals’ emo ional s eng h and con ic ions
is essen ial o deepen he unde s anding o he psychia ic and
psychological consequences o he pandemic.[29]
On he o he hand, a s udy conduc ed in New Zealand,
a coun y ha sha es his o ical ies wi h he UK, ound ha
dep ession and anxie y we e nega i ely a ec ed du ing he i s
en weeks o social dis ancing o he COVID-19 pandemic.
This was e iden in he mean sco es ob ained in ha s udy o
dep ession and anxie y du ing he COVID-19 pandemic, which
signi ican ly exceeded hose ob ained in no mal epidemiological
si ua ions.[30]
Al hough age was no a de e mining ac o in he p esen
s udy, da a om he Eu opean COVID Su ey highligh ed ha
in coun ies such as I aly o he UK, people aged 18 o 29 yea s
who had been in ec ed wi h he new co ona i us had high p e -
alence a es o dep ession and anxie y in all wa es.[31]
Wi h ega d o age, a s udy in New Zealand, men ioned
abo e, e ealed ha , al hough he mos se e e symp oms o he
disease end o de elop in olde people, i was a g oup o young
people aged 18 o 24 yea s who we e disp opo iona ely mo e
a ec ed and mo e likely o su e anxie y, s ess, and dep ession
associa ed wi h COVID-19. One explana ion o his phenom-
enon could be ha many young s uden s expe ienced academic
delays and signi ican changes in daily ou ine du ing he.[32]
O he esea ch highligh s ha younge popula ions end o ha e
poo e men al heal h ou comes in gene al.[33]
Wi h ega d o he sex a iable, i is wo h men ioning ha in
all he a icles e iewed as well as in he p esen s udy, he le el
o anxie y and, in gene al, men al heal h p oblems, was highe
in women han in men. Fo example, a s udy by Zanino o e
al epo ed a g ea e de e io a ion o men al heal h in he gen-
e al popula ion in he UK[34] in line wi h a s udy conduc ed in
Spain[17] based on he AMICO scale, which concluded ha he
p e alence o symp oms o psychological dis ess and a ec i e
diso de s in Spain p o es ha women p esen some ype o
men al heal h p oblem in 14% o he popula ion, compa ed o
7.2% o men. This may be due o he ac ha a ound 70% o
ca e wo k ends o all on women, which may ha e inc eased
due o he si ua ion o con inemen expe ienced wi h he conse-
quen closu e o schools and elewo king.[17]
As o he sala y a iable, which has also been signi ican
in he p esen s udy, an analysis conduc ed in he UK e ealed
ha he es ic ions also impac ed people’s socioeconomic
posi ion, wi h an inc ease in po e y.[34,35] In addi ion o his,
i was also ound ha people wi h men al heal h p oblems a e
subs an ially mo e likely o de elop in ec ious diseases such
as pneumonia and o su e cogni i e impai men ,[36] so lowe
socioeconomic s a us no only a ec s he quali y o men al
heal h bu also goes hand in hand wi h being mo e p one o
illness. When he in luence o socio-demog aphic a iables
dec eases, hose indi iduals who showed highe le els o dis-
ess also epo ed ha ing had COVID-19 and a g ea e num-
be o se e e symp oms.[37]
On he o he hand, he g ea e impac o li ing wi h es ic-
ions had a di ec impac on de e io a ing physical and men al
heal h, and social isola ion exace ba ed he poo men al heal h
s a us ha al eady exis ed in he UK popula ion.[38] In his
sense, he indings by Jani i e al con i m he need o be con-
ce ned no only wi h p o ec ing he physical heal h o heal h
p o essionals bu also wi h he e ec s on hei men al heal h,
some hing ha has been con i med by a la ge numbe o s ud-
ies.[39] Res ic ions also impac ed people’s socioeconomic posi-
ion, so i is no su p ising ha he majo i y o he sample
ep esen ed in his s udy chose no o sel -con ine.[40] Las ly,
al hough only 14.5% o he sample was accina ed wi h bo h
doses a he ime o he ques ionnai e, a UK s udy ound ha
a ound 82% o UK adul s a e willing o ecei e a COVID-19
accine i o e ed.[41]
Limi a ions o he p esen s udy include he ac ha
non-p obabili y sampling p ecludes accu a e knowledge o he
ep esen a i eness o he sample. On he o he hand, esea che s
mus ely on he e aci y o he da a p o ided by pa icipan s,
as hese we e sel -adminis e ed ques ionnai es. Also, du ing
he pandemic, he e ha e been si ua ions o g ea e es ic ions
depending on he cumula i e incidence o COVID-19, so he
esponse o he pa icipan s may ha e also been in luenced by
he ime a which he ques ionnai es we e comple ed. Besides, as
he da a collec ion ool is elema ic, he e may ha e also been an
accessibili y bias, as olde people and/o people a isk o social
exclusion may no ha e been able o answe he ques ionnai e.
On he o he hand, he highe numbe o women in he sam-
ple implies ano he limi a ion in i sel . The e o e, i is necessa y
o examine, h ough a new ield s udy, whe he he “sex” a i-
able may ha e such an e ec on he cons uc alida ion o he
AMICO_UK scale om a sex pe spec i e.
5. Conclusion
This s udy highligh s he need o ac ion by heal h manage s o
p o ide ca e and suppo o he gene al popula ion o he UK
in o de o mi iga e he nega i e men al heal h e ec s caused by
COVID-19.
The esul s o he p esen s udy ha e shown an a e age le el
o anxie y and FCV-19 in he gene al UK popula ion, as mea-
su ed by he AMICO UK scale.
In addi ion, he eg ession s udy showed ha women who
epo ed no ea ning enough o make ends mee , who had no
sel -con ined, and who had ecei ed only 1 dose o he accine
had highe le els o anxie y and FCV-19.
Table 3
Model adjus men and signi icance o he eg ession analysis.
S anda dized coe icien s
d F Sig. Be a Boo s apping (1000) o s anda d e o
Sex −.126 .038 1 11.121 .001
Su icien income −.170 .042 4 16.123 .000
Sel -con inemen .221 .053 2 17.212 .000
Vaccina ion .259 .111 1 5.466 .020
d = deg ee o eedom, Sig = signi icance.
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
7
Mo gado-Toscano e al. • Medicine (2023) 102:10 www.md-jou nal.com
Au ho con ibu ions
Concep ualiza ion: C is ina Mo gado-Toscano, Juan Gómez-
Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal, Lucas
Rod íguez-Jiménez, José An onio Climen -Rod íguez, Regina
Allande-Cussó.
Da a cu a ion: C is ina Mo gado-Toscano, Juan Gómez-
Salgado, Lucas Rod íguez-Jiménez, Regina Allande-Cussó.
Fo mal analysis: C is ina Mo gado-Toscano, Juan Gómez-
Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal,
Lucas Rod íguez-Jiménez, José An onio Climen -Rod íguez,
Regina Allande-Cussó.
In es iga ion: C is ina Mo gado-Toscano, Juan Gómez-Salgado,
Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal, Lucas
Rod íguez-Jiménez, José An onio Climen -Rod íguez, Regina
Allande-Cussó.
Me hodology: C is ina Mo gado-Toscano, Juan Gómez-
Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal,
Lucas Rod íguez-Jiménez, José An onio Climen -Rod íguez,
Regina Allande-Cussó.
P ojec adminis a ion: C is ina Mo gado-Toscano, Juan
Gómez-Salgado, Regina Allande-Cussó.
Resou ces: C is ina Mo gado-Toscano, Juan Gómez-Salgado,
Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal, Lucas
Rod íguez-Jiménez, José An onio Climen -Rod íguez, Regina
Allande-Cussó.
So wa e: C is ina Mo gado-Toscano, Juan Gómez-Salgado,
Lucas Rod íguez-Jiménez, Regina Allande-Cussó.
Supe ision: C is ina Mo gado-Toscano, Juan Gómez-Salgado,
Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal, Lucas
Rod íguez-Jiménez, José An onio Climen -Rod íguez, Regina
Allande-Cussó.
Valida ion: C is ina Mo gado-Toscano, Juan Gómez-Salgado,
Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal, Lucas
Rod íguez-Jiménez, José An onio Climen -Rod íguez, Regina
Allande-Cussó.
Visualiza ion: C is ina Mo gado-Toscano, Juan Gómez-
Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-Abal,
Lucas Rod íguez-Jiménez, José An onio Climen -Rod íguez,
Regina Allande-Cussó.
W i ing – o iginal d a : C is ina Mo gado-Toscano, Juan
Gómez-Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-
Abal, Lucas Rod íguez-Jiménez, José An onio Climen -
Rod íguez, Regina Allande-Cussó.
W i ing – e iew & edi ing: C is ina Mo gado-Toscano, Juan
Gómez-Salgado, Ja ie Fagundo-Ri e a, Yolanda Na a o-
Abal, Lucas Rod íguez-Jiménez, José An onio Climen -
Rod íguez, Regina Allande-Cussó.
Re e ences
[1] Johnson M. Wuhan 2019 no el co ona i us - 2019-nCoV. Ma e
Me hods. 2020;10:1–5.
[2] Shigemu a J, U sano RJ, Mo gans ein JC, e al. Public esponses o he
no el 2019 co ona i us (2019-nCoV) in Japan: men al heal h conse-
quences and a ge popula ions. Psychia y Clin Neu osci. 2020;74:281–2.
[3] B o e de en e medad po co ona i us (COVID-19): o ien aciones pa a
el público. 2020. A ailable a : h ps://www.who.in /es/eme gencies/
diseases/no el-co ona i us-2019/ad ice- o -public
[4] Spi e i G, Fielding J, Die cke M, e al. Fi s cases o co ona i us disease
2019 (COVID-19) in he WHO Eu opean Region, 24 Janua y o 21
Feb ua y 2020. Eu o Su eill. 2020;25:2000178.
[5] Bodding on NL, Cha le A, Elgoha i S, e al. Epidemiological and
clinical cha ac e is ics o ea ly COVID-19 cases, uni ed kingdom
o g ea b i ain and no he n i eland. Bull Wo ld Heal h O gan.
2021;99:178–89.
[6] Resende TC, Paschoalo o MAC, Peckham S, e al. How did he
UK go e nmen ace he global COVID-19 pandemic? Re is a de
Adminis acao Publica. 2021;55:72–83.
[7] COVID-19 dashboa d by he Cen e o Sys ems Science and Enginee ing
(CSSE) a Johns Hopkins Uni e si y (JHU). 2020. A ailable a : h ps://
co ona i us.jhu.edu/map.h ml [accessed da e Oc obe 24, 2022].
[8] P i cha d E, Ma hews PC, S oesse N, e al. .Impac o accina ion
on new SARS-CoV-2 in ec ions in he Uni ed Kingdom. Na Med.
2021;27:1370–8.
[9] Li S, Wang Y, Xue J, e al. The impac o COVID-19 epidemic decla a-
ion on psychological consequences: a s udy on ac i e weibo use s. In
J En i on Res Public Heal h. 2020;17:2032.
[10] Gómez-Salgado J, Allande-Cussó R, Domínguez S, e al. Design o ea
and anxie y o COVID-19 assessmen ool in Spanish adul popula ion.
B ain Sci. 2021;11:328.
[11] Aho su DK, Lin CY, Imani V, e al. The ea o COVID-19 scale:
de elopmen and ini ial alida ion. In J Men Heal h Addic .
2022;20:1537–45.
[12] Eps ein J, Miyuki R, Guillemin F. A e iew o guidelines o c oss-cul-
u al adap a ion o ques ionnai es could no b ing ou a consensus. J
Clin Epidemiol. 2015;68:435–41.
[13] O uño-Sie a J, Ga cía-Velasco L, Inchaus i F, e al. Nue as ap oxima-
ciones en el es udio de las p opiedades psicomé icas del STAI. Ac as
Esp Psiquia . 2016;44:83–92.
[14] Smi h KR, Woodwa d A, Campbell-Lend u D, e al. Human heal h:
impac s, adap a ion, and co-bene i s. In: Field CB, Ba os VR,
Dokken DJ, e al. Eds. Clima e Change 2014: Impac s, Adap a ion,
and Vulne abili y. Pa A: Global and Sec o al Aspec s. Con ibu ion
o Wo king G oup II o he Fi h Assessmen Repo o he
In e go e nmen al Panel on Clima e Change. Camb idge, UK; New
Yo k, NY, USA: Camb idge Uni e si y P ess. 2014.
[15] Dou ille H, Ragha an K, Renwick JA, e al. Wa e cycle changes. In:
Masson-Delmo e V, Zhai P, Pi ani A, e al. Eds. Clima e Change 2021:
he Physical Science Basis. Con ibu ion o Wo king G oup I o he
Six h Assessmen Repo o he In e go e nmen al Panel on Clima e
Change. Camb idge, UK: Camb idge Uni e si y P ess. 2021.
[16] Sene i a ne, SI, Zhang X, Adnan M, e al. 2021: Wea he and clima e
ex eme e en s in a changing clima e. In: Masson-Delmo e V, Zhai P,
Pi ani A, e al. Eds. Clima e Change 2021: he Physical Science Basis.
Con ibu ion o Wo king G oup I o he Six h Assessmen Repo o
he In e go e nmen al Panel on Clima e Change. Camb idge, UK:
Camb idge Uni e si y P ess. 2021.
[17] Gómez-Salgado J, Allande-Cussó R, Rod íguez-Domínguez C,
e al. De elopmen and c i e ion alidi y o he COVID-19 anx-
ie y and ea assessmen scale: a c oss sec ional s udy. Sci P og.
2021;104:003685042110502.
[18] He zog M, F ancis G, Cla ke A. Expe imen al design and he basics o
s a is ics: Signal De ec ion Theo y (SDT). In: He zog MH, F ancis G,
Cla ke A, eds. Unde s anding S a is ics and Expe imen al Design. NY,
USA: Sp inge In e na ional Publishing; 2019:13–22.
[19] Popula ion es ima es. 2021. A ailable a : h ps://www.ons.go .uk/peo-
plepopula ionandcommuni y/popula ionandmig a ion/popula iones i-
ma es [accessed da e No embe 3, 2022]
[20] Helminen SE, Vehkalah i M, Ke omäki TM, e al. Den is s’ selec ion o
measu es o assessmen o o al heal h isk ac o s o Finnish young
adul s. Ac a Odon ol Scand. 1999;57:225–30.
[21] Yugue o M, Hugue J, G i in S, e al. Adap ación anscul u al, alidación
y alo ación de las p opiedades psicomé icas, de la e sión española
del cues iona io Wes e n On a io Shoulde Ins abili y Index. Re is a
Española de Ci ugía O opédica y T auma ología. 2016;60:335–45.
[22] Gue a W, He e a M, Fe nández L, e al. Ca ego ical eg ession model
o he analysis and in e p e a ion o s a is ical powe . Cuban J Ag ic
Sci. 2019;53:13–20.
[23] Ho R. Handbook o Uni a ia e and Mul i a ia e Da a Analysis wi h
IBM SPSS (2nd ed.). Boca Ra ón, FL, USA: Chapman and Hall - CRC
P ess. 2014.
[24] Allande-Cussó R, Lina es-Man ique M, Gómez-Salgado J, e al. Anxie y
and ea ela ed o co ona i us disease 2019 assessmen in he Spanish pop-
ula ion: A c oss-sec ional s udy. Sci P og. 2021;104:368504211038191.
[25] Wo ld Medical Associa ion. Wo ld Medical Associa ion Decla a ion o
Helsinki: e hical p inciples o medical esea ch in ol ing human sub-
jec s. JAMA. 2013;310:2191–4.
[26] Pakpou A, G i i hs M. The ea o COVID-19 and i s ole in p e en-
i e beha io s. J Concu en Diso de s. 2020;2:58–63.
[27] Tzu Bi an D, G ossman-Gi on A, Bloch Y, e al. Fea o COVID-19
scale: psychome ic cha ac e is ics, eliabili y and alidi y in he Is aeli
popula ion. Psychia y Res. 2020;289:113100.
[28] Coelho CM, Su iwan P, A a o N, e al. On he na u e o ea and anx-
ie y igge ed by COVID-19. F on Psychol. 2020;11:581314.
[29] Mailliez M, G i i hs MD, Ca e A. Valida ion o he F ench e -
sion o he ea o COVID-19 scale and i s associa ions wi h dep es-
sion, anxie y, and di e en ial emo ions. In J Men Heal h Addic .
2022;4:2057–71.
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023
8
Mo gado-Toscano e al. • Medicine (2023) 102:10 Medicine
[30] Gas eige N, Vedha a K, Massey A, e al. Dep ession, anxi-
e y and s ess du ing he COVID-19 pandemic: esul s om a
New Zealand coho s udy on men al well-being. BMJ Open.
2021;11:e0453251–16.
[31] Hajek A, König HH. P e alence and co ela es o indi iduals sc een-
ing posi i e o dep ession and anxie y on he phq-4 in he Ge man
gene al popula ion: indings om he na ionally ep esen a i e Ge man
socio-economic panel (GSOEP). In J En i on Res Public Heal h.
2020;17:78651–11.
[32] Wa ig SL, Fo shaw MJ, Sou h J, e al. New, no ma i e, English-sample
da a o he sho o m pe cei ed s ess scale (PSS-4). J Heal h Psychol.
2013;18:1617–28.
[33] Tee ML, Tee CA, Anlacan JP, e al. Psychological impac o COVID-19
pandemic in he Philippines. J A ec Diso d. 2020;277:379–91.
[34] Zanino o P, Iob E, Demakakos P, e al. Immedia e and longe - e m
changes in he men al heal h and well-being o olde adul s in England
du ing he COVID-19 pandemic. JAMA Psychia y. 2022;79:151–9.
[35] Esha e u i C, Wa eham A, Ra ay M, e al. An explo a ion o he
impac o SARS-CoV-2 (COVID-19) es ic ions on ma ginalised
g oups in he UK. Public Heal h. 2021;197:6–10.
[36] Seminog OO, Goldac e MJ. Risk o pneumonia and pneumococcal dis-
ease in people wi h se e e men al illness: English eco d linkage s udies.
Tho ax. 2013;68:171–6.
[37] Whi ake L, Came on C, Haua i H, e al. Wha amily ci cums ances,
du ing COVID-19, impac on pa en al men al heal h in an inne ci y
communi y in London? F on Psychia y. 2021;12:1–15.
[38] Moccia L, Jani i D, Pepe M, e al. A ec i e empe amen , a achmen
s yle, and he psychological impac o he COVID-19 ou b eak: an
ea ly epo on he I alian gene al popula ion. B ain Beha Immun.
2020;87:75–9.
[39] Jani i D, Moccia L, Da oli L, e al. Emo ional dys egula ion medi-
a es he impac o childhood auma on psychological dis ess: i s
I alian da a du ing he ea ly phase o COVID-19 ou b eak. Aus N Z J
Psychia y. 2021;55:1071–8.
[40] B ooks SK, Webs e RK, Smi h LE, e al. The psychological impac o
qua an ine and how o educe i : apid e iew o he e idence. Lance .
2020;395:912–20.
[41] Robe son E, Ree e KS, Niedzwiedz CL, e al. P edic o s o COVID-19
accine hesi ancy in he UK household longi udinal s udy. B ain Beha
Immun. 2021;94:41–50.
Downloaded om h p://jou nals.lww.com/md-jou nal by BhDM 5ePHKa 1zEoum1 Q N4a+kJLhEZgbsIHo4XMi0hCy
wCX1AWnYQp/IlQ HD3i3D0OdRyi7T SFl4C 3VC4/OAVpDDa8K2+Ya6H515kE= on 09/27/2023